BRAVECARE ApS - CVR: 41391030

2022, EUR

21.07.2023

Bruttoresultat

379'

Primær drift

-18.185

Årets resultat

440

Aktiver

3.682'

Kortfristede aktiver

Na.

Egenkapital

1.227'

Afkastningsgrad

-0 %

Soliditetsgrad

33 %

Likviditetsgrad

0 %

Resultat

21.07.2023

Årsrapport	2022 21.07.2023	2021 15.07.2022	2020 28.07.2021
Nettoomsætning			0
Bruttoresultat	379.384	-123.074	0
Resultat af primær drift	-18.185	-150.596	-57.330
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0
Finansielle indtægter	19.468	3.944	0
Finansieringsomkostninger	-843	-875	0
Andre finansielle omkostninger	0	0	0
Resultat før skat	440	-147.527	-57.330
Resultat	440	-147.527	-57.330
Forslag til udbytte	0	0	0

Aktiver

21.07.2023

Årsrapport	2022 21.07.2023	2021 15.07.2022	2020 28.07.2021
Kortfristede varebeholdninger	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	2.885.710	916.892	0
Likvider	378.386	803.909	29.323
Kortfristede aktiver	0	0	29.323
Immaterielle aktiver og goodwill	380.549	647.118	0
Finansielle anlægsaktiver	0	0	0
Materielle aktiver	37.178	68.443	0
Langfristede aktiver	417.727	715.561	0
Aktiver	3.681.823	2.436.362	29.323

Aktiver

21.07.2023

Passiver

21.07.2023

Årsrapport	2022 21.07.2023	2021 15.07.2022	2020 28.07.2021
Forslag til udbytte	0	0	0
Egenkapital	1.227.004	1.336.435	-7.332
Hensatte forpligtelser	0	0	0
Langfristet gæld til banker	0	0	0
Anden langfristet gæld		0	0
Leverandører af varer og tjenesteydelser	297.308	180.214	7.474
Kortfristede forpligtelser	2.454.819	1.099.927	36.655
Gældsforpligtelser	2.454.819	1.099.927	36.655
Forpligtelser	2.454.819	1.099.927	36.655
Passiver	3.681.823	2.436.362	29.323

Passiver

21.07.2023

Nøgletal

21.07.2023

Årsrapport	2022 21.07.2023	2021 15.07.2022	2020 28.07.2021
Afkastningsgrad	-0,5 %	-6,2 %	-195,5 %
Dækningsgrad	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.
Egenkapitals-forretning	0,0 %	-11,0 %	781,9 %
Payout-ratio	Na.	Na.	Na.
Gældsdæknings-nøgletal	-2.157,2 %	-17.211,0 %	Na.
Soliditestgrad	33,3 %	54,9 %	-25,0 %
Likviditetsgrad	Na.	Na.	80,0 %

Resultat

21.07.2023

Gæld

21.07.2023

Årsrapport

21.07.2023

Nyeste:01.01.2022- 31.12.2022(offentliggjort: 21.07.2023)

Information om virksomhedens regnskabsklasse:The Annual Report of BRAVECARE ApS for 2022 has been presented in accordance with the provisions of the Danish Financial Statements Act for enterprises in reporting class B and certain provisions applying to reporting class C. Regnskabsklasse B1 true true The Annual Report is prepared consistently with the accounting principles applied last year.

Beretning

21.07.2023

Dato for ledelsens godkendelse af årsrapporten:2023-07-20

Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:Unusual matters Shareholder loan In December 2022, the company entered into an agreement with a Polish group company, Chmielewski i Kwiatkowski Spolka Jawna, for the purpose of transferring crypto currencies. The purchase price for the transfer was settled by a loan note pursuant to which the company would have a receivable against Chmielewski i Kwiatkowski Spolka Jawna corresponding to the purchase price plus market interests. For the purpose of ensuring the legality of this transaction and the hereto pertaining loan, the company engaged a Danish reputable law firm to act as legal advisors for the transaction and the loan structure. Due to an unfortunate misunderstanding, the Danish legal advice provided was based an incorrect assumption that Chmielewski i Kwiatkowski Spolka Jawna was a corporate structure that was not subject to the Danish Companies Act chapter 13, and that these provisions would not apply to the loan provided as part of the transaction. However, Chmielewski i Kwiatkowski Spolka Jawna is a Polish corporate entity corresponding to the Danish partnership (in Danish: Interessentskab). As a result of this unfortunate misunderstanding, the company has unintendedly provided an illegal shareholder loan in violation of the Danish Companies Act chapter 13 while being in good faith and acting in accordance with the legal advice provided by local reputable law firms. As soon as the company was made aware of the situation in connection with the finalization of the annual report, the company has taken all actions necessary in order to rectify this unfortunate situation including ensuring that the loan has been repaid with applicable interest. Correction to last year There was an error in the annual report for 2021, as a result of incorrect recognition of other investment assets and other expenses. Since the company, cf. applied accounting practices, measures other investments' assets at cost price, the incorrect recognition means that the company's result and equity were incorrect in 2021. The error has been incorporated into the annual report. The error has been incorporated into the annual report and causes the accounting item "Debt to affiliated companies" in the balance sheet to be increased by EUR 109,871. The equity at the beginning of 2021 will be reduced by a corresponding amount. The impact of the error is recognized directly in the equity at the beginning in the line "Correction of error", where EUR 109,871 is entered in "Retained earnings" and comparative figures are adjusted accordingly.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today the Executive Board have discussed and approved the Annual Report of BRAVECARE ApS for the financial year 1 January - 31 December 2022.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Principal activities The company's object is to focus on mental and social welfare, activities related to employment placement and education as well as management consultancy activities and any ancillary activities that are directly or indirectly related thereto. Further, it is the company's object to support group companies, own shares and to invest and carry out other investment activities as well as any ancillary activities that are directly or indirectly related thereto.